The National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) has been offered annually since 2004 (previously known as the Commercialization Assistance Program), and is designed to help some of the agency’s most promising small life science and healthcare Phase II awardees develop their commercial businesses and transition their SBIR/STTR-funded technologies into the marketplace. Applicants are selected via a competitive process for a limited number of slots in the program. Funded by NIH and managed through a contract, the CAP provides selected participants with individualized assistance toward accomplishing key commercialization goals. This is achieved through individual mentoring and consulting sessions, training workshops, access to domain experts, and focus on outcomes that will enhance the commercialization profile and readiness of participating awardees.
The latest form for Application to be Accepted in the National Institutes of Health (NIH) Technical Assistance Programs: Commercialization Accelerator Program (CAP) expires 2020-10-31 and can be found here.
Document Name |
---|
Form and Instruction |
Supplementary Document |
Supplementary Document |
Supplementary Document |
Supporting Statement A |
Approved without change |
Existing collection in use without an OMB Control Number | 2017-09-08 |